ロード中...
Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
BACKGROUND: The extent of surgery (ES) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is a well-known risk factor for major postoperative morbidity. Interestingly, the reliability of surgeons to predict the ES prior to CRS + HIPEC is unknown. METHODS: In th...
保存先:
| 出版年: | Ann Surg Oncol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7334271/ https://ncbi.nlm.nih.gov/pubmed/32052304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08237-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|